A research team at The Hong Kong University of Science and Technology (HKUST), led by Prof. LI Ping, Dean of the School of Humanities and Social Science and Chair Professor of Psychology and Cognitive Science, has found that a brief one-on-one pre-lecture conversation (8–10 minutes) — whether with a human or an AI instructor — improves students’ neural synchrony and learning outcomes.

In the era of big data and artificial intelligence, a new approach has emerged for solving combinatorial optimization problems, which involve finding the most efficient solution among many possible options and can otherwise take thousands of years to compute. A KAIST research team has developed computational hardware that can be implemented entirely using existing silicon processes, enabling deployment on existing fabrication lines without additional facilities. This is expected to enable faster and more accurate decision-making across various industries, including logistics, finance, and semiconductor design.

New study has unveiled a new method to cost-effectively and practically test for “forever chemicals” in water.

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) today announced a research partnership with MitoQ New Zealand to examine the potential role of MitoQ® (mitoquinol mesylate), a mitochondria-targeted antioxidant, in supporting healthy ageing. Building on existing scientific literature, the partnership aims to generate evidence on whether MitoQ® can slow or improve markers of biological ageing and support longevity potential. The joint study will also evaluate the effectiveness of biological ageing clocks in assessing health supplements and other interventions more rapidly than conventional long-term clinical trials.

Antibiotic resistance is making bacterial infections harder to treat, demanding new therapeutic strategies. A new review highlights bacterial extracellular vesicles (BEVs) as promising nanoscale tools that can kill pathogens, block infection, enhance vaccines, and deliver drugs. By integrating genetic, chemical, and physical engineering, researchers demonstrate how BEVs can be transformed into customizable “nanoweapons.” This approach could reshape infection treatment by enabling safer, targeted, and more effective alternatives to conventional antibiotics.

The UK‑led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset , a groundbreaking step toward accelerating the discovery of new medicines using artificial intelligence. The release makes high‑quality, standardised experimental data freely accessible to researchers worldwide, providing AI-ready data to address the most persistent barriers in AI‑driven therapeutic development.